P3 survey: 44% of U.S. patients receive inadequate relief of moderate-to-severe acute pain

NewsGuard 100/100 Score
A new survey shows almost half (44%) of U.S. patients in outpatient settings received potentially inadequate relief of moderate-to-severe acute pain.

Findings from the Physicians Partnering Against Pain (P3) Survey, one of the largest pain management surveys of physicians and patients in the United States, also show that this undertreatment was particularly prevalent among adults aged 75 and older (52%).

Janssen Scientific Affairs, LLC, formerly Ortho-McNeil Janssen Scientific Affairs, LLC, funded the survey.  An online version of the article, published in the July/August issue of the Journal of Opioid Management, may be found here.

"This large-scale survey gives us much greater insight into pain management in the real world, confirming that acute pain is widely undertreated, particularly among the older population," said Paul Chang, M.D., Vice President, Medical Affairs, Internal Medicine, Janssen Pharmaceuticals, Inc.  

The P3 survey focused on U.S. physicians and their patients with moderate-to-severe acute pain and was designed to evaluate patient perceptions of the adequacy of analgesia and the influence of opioid-related side effects in outpatient pain management.  Undertreatment of pain in older adults is a well-known problem in the United States and older adult patients may not receive opioids due to many reasons, including poor assessment of pain and adverse effects, as well as concerns about tolerance, physical dependence, and addiction.

The analysis evaluated patient-reported measures, including adequacy of pain medication through a pain management index (PMI) score, adverse effects, and actions to manage gastrointestinal adverse effects during opioid treatment. While all three age cohorts in the study reported inadequate analgesia, older patients were significantly more likely than younger patients to have inadequate pain relief, which was seen in 43 percent, 46 percent, and 52 percent of patients aged under 65, 65 to 74, 75 years and older, respectively.

Results of this survey, including data from 50,869 patients who submitted the survey between September and November 2008, are consistent with previous reports from smaller studies in other settings.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Caffeine vs. creatine: The impact on cognitive and physical performances